Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DR26FCRF4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,623
Award facts
- Contract value 100% obligated
- $25,622.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $25.6K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, issued on October 29, 2025, with an ultimate completion date of November 20, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award represents one of numerous delivery orders issued to DMS Pharmaceutical Group by the Defense Logistics Agency's Medical Supply Chain division during October 2025, with delivery to occur in Park Ridge, Illinois.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) designated SPE2DR with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999B vehicle awarded on November 13, 2025, with completion scheduled for December 31, 2036. The PPV-G GEN V represents the Defense Logistics Agency's broader $30.3B acquisition strategy to establish multiple regional prime vendor contractors supplying comprehensive pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support military healthcare facilities worldwide. EXPAREL, a specialty surgical product, aligns with DMS Pharmaceutical Group's established portfolio supplying the Department of Defense medical supply chain with diverse pharmaceutical and medical product categories.
Quick answers
Who was awarded contract SPE2DR26FCRF4?
SPE2DR26FCRF4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DR26FCRF4 worth?
The government has obligated $25,623 on SPE2DR26FCRF4.
Is contract SPE2DR26FCRF4 an order under another contract?
Yes. SPE2DR26FCRF4 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRF4 competed?
The extent of competition for SPE2DR26FCRF4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award